Long-acting injectable antipsychotics can improve adherence and long-term outcomes when implemented thoughtfully and collaboratively. This session reviews current evidence and guideline recommendations, compares available LAI formulations, and provides practical strategies for initiating, administering, and reintroducing LAIs using patient-centered communication techniques.<br><br>Supported by educational grants from Alkermes, Inc., Johnson & Johnson, and Teva Pharmaceuticals.